[ad_1]
© Svitlana Kolchyk | Dreamstime.com
The pharmaceutical company, which announced in late August that it had begun the first trials of an antibody-based treatment for the prevention and treatment of Covid-19, has halted trials around the world, including the latest trials of the experimental vaccine. , due to your Unexplained Illness in a research participant.
This vaccine has been developed by the University of Oxford and is considered one of the main candidates for vaccines against the new coronavirus, while the suspension of tests makes it more difficult to predict its possible release by the end of the year.
We remind you that the planning for the reception by our country of the first doses of vaccine from the AstraZeneca company was December (2020) with Greece participating in the joint European initiative.
The company announced that it had voluntarily stopped the trials, in order to study the safety data, by an independent committee, while working to speed up the process of analyzing the incidence, in order to minimize the possible consequences in the schedule of the testing program.
